Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Why Should You Retain Arthur J. Gallagher (AJG) In Portfolio?

Published 05/23/2017, 09:19 PM
Updated 07/09/2023, 06:31 AM

Arthur J. Gallagher & Co. (NYSE:AJG) boasts impressive growth via organic sales as well as mergers and acquisitions (M&A). The company remains focused on tapping opportunities in the U.K., Australia, New Zealand, Canada and the U.S. and intends to pursue smaller tuck-in mergers in 2017. The company’s M&A pipeline remains strong with about $350 million of revenues. In fact, the company has witnessed positive organic growth for 22 straight quarters.

However, the company expects impact from forex of about $20 million in the second quarter due to its operations across the globe. Nonetheless, the insurance broker will not experience a significant impact of forex in the second half 2017. The company’s International business accounts for 35% of its top line.

Arthur J. Gallagher aggressively pursues strategic acquisitions. To date, the company made four acquisitions in the second quarter. The company expects integration cost of about 1 cent per quarter or 4 cents per share in 2017.

Also, the company’s dividend yield of 2.77% is above the industry average of 1.38%. This makes the insurer an attractive pick for yield-seeking investors. The company now has 7.7 million shares remaining under its repurchase authorization.

The Zacks Rank #3 (Hold) insurance broker beat expectations in three of the last four quarters with an average positive surprise of 1.23%. The company has witnessed estimates moving north over the last 30 days.

Valuation remains attractive on a price to earnings as well as on a price to book basis. The P/E ratio is 18.9, a discount of 0.5% to the industry average. Also, price to book multiple of 2.7 is 25% lower than industry average of 3.6.

Shares of Arthur J. Gallagher gained about 9.12% year to date. Though the company’s shares underperformed the Zacks categorized Insurance Broker industry growth of 10.19%, we believe that solid organic and inorganic background, strong balance sheet and effective capital deployment bodes well for long-term growth and should drive the stock higher. The expected long-term earnings growth rate is currently pegged at 9.3%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Stocks to Consider

Some better-ranked stocks from the insurance industry are eHealth, Inc. (NASDAQ:EHTH) , American Financial Group, Inc. (NYSE:AFG) and ProAssurance Corporation (NYSE:PRA) .

eHealth provides private online health insurance services in the United States and China. The company posted a positive earnings surprise of 596.15% in the last reported quarter. The stock flaunts a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

American Financial Group engages primarily in property and casualty (P&C) insurance with focus on specialized commercial products for businesses. The company posted a positive earnings surprise of 23.36% in the last reported quarter. The stock sports a Zacks Rank #1.

ProAssurance provides P&C insurance, and reinsurance products in the United States. The company posted a positive earnings surprise of 12.72% in the last reported quarter. The stock carries a Zacks Rank #2.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look. See the pot trades we're targeting>>



eHealth, Inc. (EHTH): Free Stock Analysis Report

Arthur J. Gallagher & Co. (AJG): Free Stock Analysis Report

ProAssurance Corporation (PRA): Free Stock Analysis Report

American Financial Group, Inc. (AFG): Free Stock Analysis Report
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.